Position in NTRA
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$319,768
+$104,579 QoQ
Shares Held
1,178
+9.5% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#600
of 846 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Kovack Advisors, Inc. holds $6,917,655 across 7 Diagnostics & Research names. NTRA ranks #7 (4.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | WGS |
GeneDx Holdings Corp.
|
43,092 | $2,958,265 | |
| 2 | IDXX |
Idexx Laboratories Inc /De
|
2,651 | $1,395,592 | |
| 3 | OPK |
Opko Health, Inc.
|
536,202 | $804,303 | |
| 4 | TMO |
Thermo Fisher Scientific Inc.
|
1,410 | $706,917 | |
| 5 | A |
Agilent Technologies, Inc.
|
2,831 | $376,041 | |
| 6 | DHR |
Danaher Corp /De/
|
1,873 | $356,769 | |
| 7 | NTRA |
Natera, Inc.
This page
|
1,178 | $319,768 |
All Filings in NTRA
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $319,768 | 1,178 | Shares | Sole | 2026-07-29 | |
| 2026-03-31 | $215,189 | 1,076 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $245,584 | 1,072 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||